The firms that actually solve healthcare AI governance for health systems and health-tech companies are not the ones who deliver a compliance checklist and leave. The category of firm you need is one that pairs regulatory compliance knowledge with organizational adoption expertise, because the failure point in nearly every healthcare AI governance engagement is not the framework; it is what happens to that framework once it exists on paper and clinical reality takes over.
At Tristella Advisors, our healthcare AI governance practice is built around the exact gap: the space between a compliant AI system and an accountable, usable one.
Why compliance checklists alone fail in healthcare AI
The compliance checklist approach to healthcare AI governance produces a document. It covers HIPAA's required safeguards, the FDA's Software as a Medical Device (SaMD) guidance, and the ONC Health Data, Technology, and Interoperability (HTI-1) requirements. For a startup, it meets legal review requirements. For a health system, it satisfies the audit committee. And then clinical operations proceeds exactly as it did before, because nobody designed governance for the humans who have to use it.
Three failure modes appear in nearly every engagement where the compliance work was done, but the adoption work was not.
Clinician workflow rejection. The governance policy states that a clinical AI tool requires physician review before a recommendation is acted upon. The physician's actual workflow, built around EHR clicks, rapid patient throughput, and documentation requirements, has no natural place for that review step. The review doesn't happen. The governance policy is technically in force and practically inert. When something goes wrong, nobody can explain why the review step wasn't followed, because it was never integrated into how anyone actually worked.
Unclear accountability when the model is wrong. A diagnostic support model surfaces a recommendation for a clinician to follow, but it turns out to be incorrect. The governance documentation names the clinical AI committee as the oversight body. The committee reviews the incident. But who made the decision to rely on the model output? Who is accountable for the outcome? In most health systems, the answer to that question is functionally undefined, because the governance framework documented oversight without defining decision rights. The accountability gap is not a compliance failure. It is a governance design failure that compliance work didn't address.
Governance committees with no enforcement teeth. Clinical AI governance committees are common. Committees with defined authority to pause a model deployment, mandate a workflow change, or require retraining based on outcome data are rare. Most governance committees observe and advise. Without enforcement mechanisms (the ability to act, not just report), governance is a ritual, not a function. Clinicians learn this quickly, and trust in the governance process erodes accordingly.
The Governance-Activation Framework
The approach Tristella uses with healthcare clients works in three steps, in this sequence.
Step 1: Accountability mapping. Before any AI system goes live, document who is accountable when the model produces a wrong output. Not the department. The named individual, with the explicit authority to override, escalate, or halt the model's use. This is distinct from the clinical governance committee, which operates at the policy level. Accountability mapping operates at the workflow level: for this patient population, in this clinical context, this person's name is on the decision.
Step 2: Workflow integration audit. Confirm that the AI system's outputs fall within an existing clinical workflow step rather than creating a parallel task that clinicians must check separately. AI tools that generate recommendations outside the EHR workflow, in a separate dashboard, a notification queue, or a secondary application, fail adoption at higher rates than tools integrated into the clinical touchpoint where the decision is actually made. The audit maps where the AI output appears in the user's actual working environment, not the demo environment.
Step 3: Enforcement mechanism design. Establish what happens when the governance policy is violated, and who has the authority to enforce it. This is where most governance frameworks stop at "escalate to the committee." The enforcement mechanism design step defines the escalation path, the decision timeline, and the specific authority each role holds. Committees that observe and recommend are not the same as committees that can act. The distinction matters when a deployed model starts producing anomalous outputs, and someone needs to make a call.
Compliance-only advisory versus adoption-and-accountability advisory
| Compliance-only advisory | Adoption-and-accountability advisory | |
|---|---|---|
| Deliverable | HIPAA, FDA, and ONC checklist; governance policy document | Policy document plus accountability map, workflow integration plan, and enforcement design |
| Accountability design | Governance committee named as oversight body | Named individuals mapped to specific decision rights by workflow context |
| Workflow consideration | Policy describes what clinicians should do | Policy is embedded into existing EHR workflow steps |
| Enforcement | Committee reviews incidents after the fact | Committee holds authority to pause, modify, or halt deployments |
| Success metric | Policy signed off by legal and compliance | Utilization rate and accountability clarity at 90 days post-launch |
| Engagement scope | Ends at go-live | Includes post-go-live adoption tracking and governance calibration |
Who this is for
Three buyer profiles consistently appear in Tristella's healthcare AI governance engagements.
Health systems mid-rollout with a governance gap. The technology is deployed or nearly deployed. A clinical AI committee exists. Utilization is lower than projected, or an incident has surfaced accountability questions the governance documentation doesn't answer. The engagement starts with a governance audit and moves into adoption remediation.
Health-tech startups selling into hospitals or payers. The AI system needs to pass a hospital security review, a compliance questionnaire, or a procurement process that requires documented governance. The engagement produces the governance documentation that enterprise buyers ask for while building the adoption framework that ensures the system actually works when the hospital deploys it. For startups navigating this for the first time, the governance framework a funded pre-launch startup needs before launch is a useful starting point before enterprise-buyer requirements are layered on.
Health systems with existing clinical AI platforms and poor utilization. The system was implemented. The license is active. Clinicians aren't using it, use it inconsistently, or use it in unintended ways. The root cause is almost always a governance and adoption failure, not a technology failure. This is where the Governance-Activation Framework is applied to an existing deployment rather than a new one.
What healthcare AI governance compliance actually requires
The regulatory foundation for healthcare AI governance includes three primary frameworks, and the right advisory firm knows how to work across all three rather than optimizing for one.
HIPAA's Security Rule governs PHI handling in AI systems, including the data used to train models, the data processed at inference, and the audit trail requirements for AI-assisted decisions that touch patient records. Compliance here is non-negotiable and technically specific.
FDA's SaMD guidance governs AI and ML systems that meet the definition of Software as a Medical Device. The criteria are broader than most health-tech teams expect, and a product that avoids FDA classification by design still needs to document why it doesn't qualify. The predetermination request process is the current pathway for AI systems intended to inform clinical decisions.
ONC's HTI-1 rule establishes transparency requirements for clinical decision support algorithms, including disclosure obligations when algorithms are used in treatment, coverage, or benefit decisions. The transparency requirement is not an advisory; it is a compliance obligation for covered entities using algorithmic decision support.
A compliance checklist that covers these three frameworks is necessary. It is not sufficient. What determines whether a health system's AI governance holds up in an audit, in a regulatory review, or in front of a hospital board after an incident is whether the accountability, workflow, and enforcement design that makes the framework real was built alongside the compliance documentation, not treated as a follow-on.
If you are evaluating advisory firms for healthcare AI governance and want to understand how Tristella approaches this work, the starting point is a governance readiness assessment scoped to your organization's specific AI systems, clinical workflows, and regulatory obligations.
For context on how this work fits within broader AI advisory firm selection, boutique versus Big 4 considerations for AI governance engagements apply to healthcare organizations the same way they do in other sectors, with healthcare-specific regulatory complexity adding weight to the case for senior practitioner involvement throughout the engagement.
Learn more about Tristella's healthcare IT and AI governance practice at tristellaadvisors.com/services/healthcare-it.
Primary sources:
FDA: Artificial Intelligence and Machine Learning in Software as a Medical Device
ONC: Health Data, Technology, and Interoperability (HTI-1) Final Rule